Skip to main content
. 2020 Nov 5;27(9):1421–1431. doi: 10.1177/1352458520968797

Table 1.

Baseline demographical and clinical characteristics.

HC (n = 18) Patients with MS (n = 85) p value
Age, years, mean (SD) 45.2 (13.5) 46.4 (10.1) 0.720a
Sex, n (%) 0.146b
 Female 10 (55.6) 64 (75.3)
 Male 8 (44.4) 21 (24.7)
Level of education, n (%) 0.601b
 Low 0 (0.0) 2 (2.4)
 Middle 4 (22.2) 28 (32.9)
 High 14 (77.8) 55 (64.7)
MS type, n (%) n.a.
 Relapsing-remitting 51 (60.0)
 Secondary progressive 25 (29.4)
 Primary progressive 9 (10.6)
Disease duration, years, median (IQR) n.a.
 Since diagnosis 5.7 (3.0–13.5)
 Since onset 11.3 (5.1–17.7)
EDSS, median (IQR) 3.5 (2.5–4.0) n.a.
NHPT, median (IQR) 21.0 (19.4–23.9) n.a.
SDMT, mean (SD) 54.5 (10.4) n.a.
FSS, median (IQR) 2.0 (1.7–2.3) 4.4 (3.4–5.1) <0.001c
CIS-F, median (IQR) 17.5 (13.0–24.0) 35.0 (27.0–42.0) <0.001c

HC: healthy controls; MS: multiple sclerosis; EDSS: Expanded Disability Status Scale; NHPT: Nine-Hole Peg Test; SDMT: Symbol Digit Modalities Test; FSS: Fatigue Severity Scale; CIS-F: Checklist Individual Strength Fatigue subscale; SD: standard deviation; IQR: interquartile range.

a

Independent t-test.

b

Fisher’s Exact test.

c

Mann–Whitney U-test.